Efficacy and Safety of PI3K Inhibitors in Relapsed/Refractory Large Granular T Lymphocytic Leukemia
Condition: Relapsed/Refractory Large Granular T Lymphocytic Leukemia Intervention: Drug: Linperlisib Sponsors: Institute of Hematology & Blood Diseases Hospital; YL-Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials